In a report released today, Jo Walton from UBS maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target of €115.00. The ...

Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial ...

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 inhibitor. The ...

Both GenZ and Millennials are growing more self-assured about maneuvering romantic connections, even though the two ...

In a report released today, Emily Field from Barclays maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target of ...

France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its ...

Quarterly business operating income, excluding one-off items, rose 20.1% to 2.90 billion euros ($3.29 billion), surpassing the average analyst estimate of 2.68 billion euros. The company reported net ...

The U.S. pays the most for drugs in the world, often nearly three times that of other developed nations. "European price ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...